Lycopene is a carotenoid present in human serum and skin as well as the liver, adrenal glands, lungs, prostate and colon. Lycopene has been found to possess antioxidant and antiproliferative properties in animal and laboratory studies, although activity in humans remains controversial.
Numerous studies correlate high intake of lycopene-containing foods or high lycopene serum levels with reduced incidence of cancer, cardiovascular disease, and macular degeneration. However, estimates of lycopene consumption have been based on reported tomato intake, not on the use of lycopene supplements. Since tomatoes are sources of other nutrients, including vitamin C, folate, and potassium, it is not clear that lycopene itself is beneficial.
There is no well-established definition of "lycopene deficiency," and direct evidence that repletion of low lycopene levels has any benefit is lacking.
Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs. orchidectomy alone in the management of advanced prostate cancer. BJU Int 2003;92(4):375-378. View Abstract
Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood) 2002;227(10):886-893. View Abstract
Briviba K, Kulling SE, Moseneder J, et al. Effects of supplementing a low-carotenoid diet with a tomato extract for 2 weeks on endogenous levels of DNA single strand breaks and immune functions in healthy non-smokers and smokers. Carcinogenesis 2004;25(12):2373-2378. View Abstract
Bunker CH, McDonald AC, Evans RW, et al. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 2007;57(2):130-7. View Abstract
Chandra RV, Prabhuji ML, Roopa DA, et al. Efficacy of lycopene in the treatment of gingivitis: a randomised, placebo-controlled clinical trial. Oral Health Prev Dent 2007;5(4):327-36. View Abstract
Chong EW, Wong TY, Kreis AJ, et al. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 2007 Oct 13;335(7623):755. View Abstract
Clark PE, Hall MC, Borden LS Jr, et al. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology 2006 Jun;67(6):1257-61. View Abstract
Gianetti J, Pedrinelli R, Petrucci R, et al. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 2002;143(3):467-474. View Abstract
Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002;94(5):391-398. View Abstract
Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility--a preliminary report. Int Urol Nephrol 2002;34(3):369-372. View Abstract
Jatoi A, Burch P, Hillman D, et al. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 2007 Feb;69(2):289-94. View Abstract
Kumar A, Bagewadi A, Keluskar V, et al. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 Feb;103(2):207-13. View Abstract
Schwarz S, Obermüller-Jevic UC, Hellmis E, et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 2008 Jan;138(1):49-53. View Abstract
Singh M, Krishanappa R, Bagewadi A, et al. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 2004;40(6):591-596. View Abstract
Vaishampayan U, Hussain M, Banerjee M, et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer 2007;59(1):1-7. View Abstract